Showing results (61-70 of 254) with videos related to

Sort By:
Pageof 26
Expert Opinion on Investigational Drugs|July 13, 2018
IPH4102, a monoclonal antibody directed against the immune receptor molecule KIR3DL2, for the treatment of cutaneous T-cell lymphomaCarrie Van Der Weyden, Martine Bagot, Paul Neeson, et al.
Leukemia & Lymphoma|August 16, 2012
Efficacy and safety of denileukin diftitox retreatment in patients with relapsed cutaneous T-cell lymphomaMadeleine Duvic, Ann G Martin, Elise A Olsen, et al.
The Australasian Journal of Dermatology|November 18, 2003
Management of the primary cutaneous lymphomasH Miles Prince, Christopher McCormack, Gail Ryan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 21, 2008
The use of experimental murine models to assess novel agents of hematopoietic stem and progenitor cell mobilizationKirsten E Herbert, Jean-Pierre Lévesque, David N Haylock, et al.
Leukemia & Lymphoma|June 29, 2012
Denileukin diftitox for the treatment of CD25 low-expression mycosis fungoides and Sézary syndromeH Miles Prince, Ann G Martin, Elise A Olsen, et al.
Journal of the American Academy of Dermatology|July 29, 2008
Extracorporeal photopheresis for the treatment of Sézary syndrome using a novel treatment protocolSuzanne Arulogun, H Miles Prince, Peter Gambell, et al.
British Journal of Haematology|December 24, 2005
Spectrum of infection, risk and recommendations for prophylaxis and screening among patients with lymphoproliferative disorders treated with alemtuzumab*Karin A Thursky, Leon J Worth, John F Seymour, et al.
European Journal of Haematology|November 4, 2004
Alemtuzumab: effective monotherapy for simultaneous B-cell chronic lymphocytic leukaemia and Sézary syndromeSimon D J Gibbs, Kirsten E Herbert, Christopher McCormack, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 6, 2022
Cost-Effectiveness of Extracorporeal Photopheresis for the Treatment of Patients With Erythrodermic (Stage T<sub>4</sub>, M<sub>0</sub>) Cutaneous T-Cell Lymphoma in the Australian SettingAdrian Peacock, Francis Dehle, Oscar Alejandro Mesa Zapata, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 31, 2006
Development of neuropathy in patients with myeloma treated with thalidomide: patterns of occurrence and the role of electrophysiologic monitoringLinda Mileshkin, Richard Stark, Bruce Day, et al.
Pageof 26